Update on Emerging Treatment Options for Primary Biliary Cholangitis
Maria T Aguilar,1 David M Chascsa2 1Department of Gastroenterology & Hepatology, Mayo Clinic, Scottsdale, AZ, USA; 2Department of Gastroenterology & Hepatology, Mayo Clinic, Phoenix, AZ, USACorrespondence: Maria T Aguilar Email aguilar.maria1@mayo.eduAbstract: Primary biliary cholang...
Guardado en:
Autores principales: | Aguilar MT, Chascsa DM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a79fd9431735437a96d7dd425b5d7d37 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarkers for primary biliary cholangitis: current perspectives
por: Kouroumalis E, et al.
Publicado: (2018) -
Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection
por: Bowlus CL
Publicado: (2016) -
Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life
por: Sivakumar T, et al.
Publicado: (2021) -
Nasobiliary Drain Diverted through a Percutaneous Endoscopic Gastrostomy Tube: A Novel Approach to Nasobiliary Drainage
por: Nikolaos Dimitrios Pantzaris, et al.
Publicado: (2021) -
Spleen-preserving surgical treatment of splenic artery aneurysm secondary to chronic pancreatitis and primary biliary cholangitis
por: Tanasković Slobodan, et al.
Publicado: (2021)